Tag: programs

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

Châtillon, France, June 5, 2026

TERRE HAUTE, Ind., June 05, 2026 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that its subsidiary, Hallador Power Company, LLC (“Hallador Power”), was selected by the U.S. Department of Energy’s (“DOE”) Hydrocarbons and Geothermal Energy Office to begin award negotiations for up to $27.2 million, in potential federal funding to modernize the Merom Generating Station (“MGS”) located in Merom, Indiana. Total project cost is estimated to be approximately $56.9 million. The comprehensive modernization project is designed to upgrade MGS’s water management systems to position the plant for future federal Effluent Limitation Guidelines (ELG) requirements. This project will help modernize the delivery of reliable and flexible energy to MISO zone 6.